Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
Clinical trial NCT04014166 · COMPLETED
Trial details
- NCT number
- NCT04014166
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2023-02-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.